title: Management and prevention of neonatal anemia: current evidence and guidelines.
abstract: Neonatal anemia is a common disorder, particularly in (very) preterm neonates. Management of neonatal anemia is based principally on red blood cell (RBC) transfusion. Although the use of blood products is nowadays widespread in neonatal medicine, evidence on the potential benefit is extremely limited. Recent studies suggest that RBC transfusions in newborns may be associated with an increased risk for necrotizing enterocolitis, transfer of infectious agents and negative effects on neurodevelopmental outcome. Whether the benefits of RBC transfusions outweigh the risks is controversial and requires further studies. In this review, we summarize the current evidence on the management of neonatal anemia and compare the various international guidelines. In addition, we discuss the various strategies to prevent neonatal anemia and reduce the need for RBC transfusions and discuss important trials currently enrolling patients to improve the management in neonatal anemia.
authors: Department of Pediatrics, Division of Neonatology, Leiden University Medical Centre, Leiden, The Netherlands.
authors: Jeannette S
authors: JS
authors: von Lindern
authors: Enrico
authors: E
authors: Lopriore
mesh_terms: D000751:Anemia, Neonatal / Q000517:prevention & control / Q000628:therapy*; D036101:Cord Blood Stem Cell Transplantation; D016208:Databases, Factual; D020345:Enterocolitis, Necrotizing / Q000209:etiology; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D004921:Erythropoietin / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D007231:Infant, Newborn; D012307:Risk Factors
chemical_list: D004921:Erythropoietin